Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2004 Nov;59(11):977–980. doi: 10.1136/thx.2004.026336

Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF

W Lawson 1, S Grant 1, V Ambrosini 1, K Womble 1, E Dawson 1, K Lane 1, C Markin 1, E Renzoni 1, P Lympany 1, A Thomas 1, J Roldan 1, T Scott 1, T Blackwell 1, J Phillips 1, J Loyd 1, R M du Bois 1
PMCID: PMC1746860  PMID: 15516475

Abstract

Background: While idiopathic pulmonary fibrosis (IPF) is one of the most common forms of interstitial lung disease, the aetiology of IPF is poorly understood. Familial cases of pulmonary fibrosis suggest a genetic basis for some forms of the disease. Recent reports have linked genetic mutations in surfactant protein C (SFTPC) with familial forms of pulmonary fibrosis, including one large family in which a number of family members were diagnosed with usual interstitial pneumonitis (UIP), the pathological correlate to IPF. Because of this finding in familial cases of pulmonary fibrosis, we searched for SFTPC mutations in a cohort of sporadic cases of UIP and non-specific interstitial pneumonitis (NSIP).

Methods: The gene for SFTPC was sequenced in 89 patients diagnosed with UIP, 46 patients with NSIP, and 104 normal controls.

Results: Ten single nucleotide polymorphisms in the SFTPC sequence were found in IPF patients and not in controls. Only one of these created an exonic change resulting in a change in amino acid sequence. In this case, a T to C substitution resulted in a change in amino acid 73 of the precursor protein from isoleucine to threonine. Of the remaining polymorphisms, one was in the 5' UTR, two were exonic without predicted amino acid sequence changes, and six were intronic. One intronic mutation suggested a potential enhancement of a splicing site.

Conclusions: Mutations in SFTPC are identified infrequently in this patient population. These findings indicate that SFTPC mutations do not contribute to the pathogenesis of IPF in the majority of sporadic cases.

Full Text

The Full Text of this article is available as a PDF (80.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amin R. S., Wert S. E., Baughman R. P., Tomashefski J. F., Jr, Nogee L. M., Brody A. S., Hull W. M., Whitsett J. A. Surfactant protein deficiency in familial interstitial lung disease. J Pediatr. 2001 Jul;139(1):85–92. doi: 10.1067/mpd.2001.114545. [DOI] [PubMed] [Google Scholar]
  2. Beers M. F., Lomax C. A., Russo S. J. Synthetic processing of surfactant protein C by alevolar epithelial cells. The COOH terminus of proSP-C is required for post-translational targeting and proteolysis. J Biol Chem. 1998 Jun 12;273(24):15287–15293. doi: 10.1074/jbc.273.24.15287. [DOI] [PubMed] [Google Scholar]
  3. Brasch F., Griese M., Tredano M., Johnen G., Ochs M., Rieger C., Mulugeta S., Müller K. M., Bahuau M., Beers M. F. Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene. Eur Respir J. 2004 Jul;24(1):30–39. doi: 10.1183/09031936.04.00000104. [DOI] [PubMed] [Google Scholar]
  4. Cartegni Luca, Wang Jinhua, Zhu Zhengwei, Zhang Michael Q., Krainer Adrian R. ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res. 2003 Jul 1;31(13):3568–3571. doi: 10.1093/nar/gkg616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Glasser Stephan W., Detmer Emily A., Ikegami Machiko, Na Cheng-Lun, Stahlman Mildred T., Whitsett Jeffrey A. Pneumonitis and emphysema in sp-C gene targeted mice. J Biol Chem. 2003 Jan 7;278(16):14291–14298. doi: 10.1074/jbc.M210909200. [DOI] [PubMed] [Google Scholar]
  6. Hodgson U., Laitinen T., Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax. 2002 Apr;57(4):338–342. doi: 10.1136/thorax.57.4.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Marshall R. P., Puddicombe A., Cookson W. O., Laurent G. J. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax. 2000 Feb;55(2):143–146. doi: 10.1136/thorax.55.2.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mollenkopf Hans-Joachim, Kursar Mischo, Kaufmann Stefan H. E. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection. J Infect Dis. 2004 Jul 6;190(3):588–597. doi: 10.1086/422394. [DOI] [PubMed] [Google Scholar]
  9. Nissim-Rafinia Malka, Kerem Batsheva. Splicing regulation as a potential genetic modifier. Trends Genet. 2002 Mar;18(3):123–127. doi: 10.1016/s0168-9525(01)02619-1. [DOI] [PubMed] [Google Scholar]
  10. Nogee L. M., Dunbar A. E., 3rd, Wert S. E., Askin F., Hamvas A., Whitsett J. A. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med. 2001 Feb 22;344(8):573–579. doi: 10.1056/NEJM200102223440805. [DOI] [PubMed] [Google Scholar]
  11. Stickeler E., Kittrell F., Medina D., Berget S. M. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene. 1999 Jun 17;18(24):3574–3582. doi: 10.1038/sj.onc.1202671. [DOI] [PubMed] [Google Scholar]
  12. Thomas Alan Q., Lane Kirk, Phillips John, 3rd, Prince Melissa, Markin Cheryl, Speer Marcy, Schwartz David A., Gaddipati Radhika, Marney Annis, Johnson Joyce. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med. 2002 May 1;165(9):1322–1328. doi: 10.1164/rccm.200112-123OC. [DOI] [PubMed] [Google Scholar]
  13. Tredano Mohammed, Griese Matthias, Brasch Frank, Schumacher Silja, de Blic Jacques, Marque Stéphanie, Houdayer Claude, Elion Jacques, Couderc Rémy, Bahuau Michel. Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease. Am J Med Genet A. 2004 Apr 1;126A(1):18–26. doi: 10.1002/ajmg.a.20670. [DOI] [PubMed] [Google Scholar]
  14. Whitsett Jeffrey A., Weaver Timothy E. Hydrophobic surfactant proteins in lung function and disease. N Engl J Med. 2002 Dec 26;347(26):2141–2148. doi: 10.1056/NEJMra022387. [DOI] [PubMed] [Google Scholar]
  15. Whyte M., Hubbard R., Meliconi R., Whidborne M., Eaton V., Bingle C., Timms J., Duff G., Facchini A., Pacilli A. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):755–758. doi: 10.1164/ajrccm.162.2.9909053. [DOI] [PubMed] [Google Scholar]
  16. Xaubet Antoni, Marin-Arguedas Alejandra, Lario Sergio, Ancochea Julio, Morell Ferran, Ruiz-Manzano Juan, Rodriguez-Becerra Eulogio, Rodriguez-Arias Jose M., Inigo Pablo, Sanz Sergi. Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003 May 13;168(4):431–435. doi: 10.1164/rccm.200210-1165OC. [DOI] [PubMed] [Google Scholar]
  17. Zorzetto Michele, Ferrarotti Ilaria, Trisolini Rocco, Lazzari Agli Luigi, Scabini Roberta, Novo Monique, De Silvestri Annalisa, Patelli Marco, Martinetti Miryam, Cuccia MariaClara. Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003 May 28;168(3):330–334. doi: 10.1164/rccm.200302-221OC. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Web-only table]
thorax_59_11_977_v2_index.html (1.2KB, html)
thorax_59_11_977_v2_1.pdf (29.9KB, pdf)

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES